Literature DB >> 18564634

Selective immunoglobulin M deficiency in an adult with Streptococcus pneumoniae sepsis and invasive aspergillosis.

R Hong1, S Gupta.   

Abstract

Primary selective immunoglobulin (Ig) M deficiency usually presents early in life with recurrent or severe infections caused by encapsulated and gram-negative organisms. Primary selective IgM deficiency in adults is rare and is usually associated with autoimmune diseases or malignant neoplasm. We performed an extensive immunological analysis of innate and adaptive immunity in an adult patient with possible primary selective IgM deficiency who presented with life-threatening Streptococcus pneumoniae septic shock and invasive Aspergillus fumigatus infection. The patient had no evidence of autoimmune disease or malignant neoplasm. Serum IgG, IgA, and IgE were normal; however, serum IgM levels and specific antibody titers against all 14 pneumococcal polysaccharide serotypes were consistently low. Complement CH50, C3, C4, and neutrophil phagocytosis and oxidative burst were normal. Toll-like receptor expression on monocytes was also normal. Therefore, adult patients with serious life-threatening and unusual infections should be investigated for possible selective primary IgM deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564634

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  12 in total

Review 1.  Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature.

Authors:  Zita Chovancova; Pavlina Kralickova; Alena Pejchalova; Marketa Bloomfield; Jana Nechvatalova; Marcela Vlkova; Jiri Litzman
Journal:  J Clin Immunol       Date:  2017-07-21       Impact factor: 8.317

2.  Defining Primary Selective IgM Deficiency.

Authors:  Sudhir Gupta; Ankmalika Gupta
Journal:  J Clin Immunol       Date:  2019-05-09       Impact factor: 8.317

3.  Analysis of subsets of B cells, Breg, CD4Treg and CD8Treg cells in adult patients with primary selective IgM deficiency.

Authors:  Ankmalika Gupta Louis; Sudhanshu Agrawal; Sudhir Gupta
Journal:  Am J Clin Exp Immunol       Date:  2016-03-23

Review 4.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Authors:  Lumin Zhang; Zihai Li; Zhuang Wan; Andrew Kilby; J Michael Kilby; Wei Jiang
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

5.  IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigens.

Authors:  Paul J Maglione; Noa Simchoni; Samuel Black; Lin Radigan; Jessica R Overbey; Emilia Bagiella; James B Bussel; Xavier Bossuyt; Jean-Laurent Casanova; Isabelle Meyts; Andrea Cerutti; Capucine Picard; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

Review 6.  Primary selective IgM deficiency: an ignored immunodeficiency.

Authors:  Ankmalika Gupta Louis; Sudhir Gupta
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

7.  IgAλ monoclonal gammopathy of undetermined significance (MGUS) associated with primary selective IgM deficiency.

Authors:  Sudhir Gupta; Sudhanshu Agrawal
Journal:  Am J Clin Exp Immunol       Date:  2019-08-15

Review 8.  Selective IgM Deficiency-An Underestimated Primary Immunodeficiency.

Authors:  Sudhir Gupta; Ankmalika Gupta
Journal:  Front Immunol       Date:  2017-09-05       Impact factor: 7.561

9.  Adrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after stroke.

Authors:  Laura McCulloch; Craig J Smith; Barry W McColl
Journal:  Nat Commun       Date:  2017-04-19       Impact factor: 14.919

10.  Embolizing pulmonary aspergillosis, mycobacterial & aspergillous splenic abscess and cytomegalovirus co-infection following steroid induced immunosuppression: a case report.

Authors:  Harsha Anuruddhika Dissanayake; Praveen Nilendra Weeratunga; Panduka Karunanayake; Rushika D Lanerolle; M V Chandu de Silva; Saroj Jayasinghe
Journal:  BMC Infect Dis       Date:  2018-08-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.